Here are Doug Kass' top thoughts on some of the biggest stories of the week.


Sticking With Amgen Short

I am sticking with my Amgen ( AMGN) short though it is down by another $2 (now below $182).
 
This is another one confidently recommended in the business media because of the clear bullish chart pattern at $187 recently.
 
My strong suspicion is that if the share price continues to decline, there will not likely be a follow-up and admission that the confident forecast was misguided.
 
So goes life in the biz media, where the positives are emphasized and the negatives are typically ignored.
 
Position: Short AMGN .


P&G Reports; I'm Not Impressed

The initial response to Procter & Gamble's ( PG) earnings was positive.
 
I think this will prove to be an incorrect response.
 
P&G, Unilever ( UN) and Modelez ( MDLZ) are three consumer packaged goods shorts that reside on my Best Ideas List.
 
All three face formidable headwinds, from my perch.
 
Position: Short PG, UN, MDLZ.
 
Originally published Oct. 20 at 7:26 a.m. EDT
 
Doug Kass shares his views every day on RealMoneyPro. Click here for a real-time look at his insights and musings. This week he blogged on:
  • How he's putting off the inevitable
  • How he feels about FANG

Click here for information on RealMoney, where you can see all the blogs, including Doug Kass'--and reader comments--in real time.

More of What's Trending on TheStreet:

More from Investing

Novice Trade: MSFT

Novice Trade: MSFT

UnitedHealth Group: A Steady Performer With Room to Run

UnitedHealth Group: A Steady Performer With Room to Run

Dollar Tree Spikes on Reported Carl Icahn Stake

Dollar Tree Spikes on Reported Carl Icahn Stake

Marathon Petroleum Moves Up but Needs More Volume to Keep the Trend Pumping

Marathon Petroleum Moves Up but Needs More Volume to Keep the Trend Pumping

O Canada: Recreational Cannabis Use Becomes Legal Wednesday

O Canada: Recreational Cannabis Use Becomes Legal Wednesday